Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Autolus
Biotech
BioNTech passes on Autolus' CAR-T amid pipeline prioritization
One year after securing a chance to co-develop the Autolus prospect, BioNTech let the option expire as part of its portfolio prioritization.
Nick Paul Taylor
Mar 20, 2025 9:11am
BioNTech pays Autolus $250M to use manufacturing, CAR-T tech
Feb 8, 2024 9:17am
Volatile day for CAR-T biotechs after FDA reveals safety review
Nov 28, 2023 4:35pm
Syncona blames biotech bear market for 'disappointing' returns
Feb 7, 2023 10:31am
Autolus outlines path to FDA after CAR-T trial hits endpoint
Dec 9, 2022 9:15am
Moderna licenses Autolus' targeting tech for cancer project
Oct 12, 2022 10:15am
